Ligand Pharma (NASDAQ: LGND) announces it has expanded its global license and supply agreements with SAGE Therapeutics (Nasdaq: SAGE) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE